{
    "Trade/Device Name(s)": [
        "Omega Laboratories Hair Drug Screening Assay for Opiates, Oxycodone and Hydrocodone",
        "Omega Laboratories Hair Drug Screening Assays for Opiates, Oxycodone and Hydrocodone"
    ],
    "Submitter Information": "Omega Laboratories, Inc.",
    "510(k) Number": "K103161",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042725",
        "K014101"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "November 28, 2011",
    "Summary Letter Received Date": "November 30, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Morphine",
        "Opiates",
        "Oxycodone",
        "Hydrocodone"
    ],
    "Specimen Type(s)": [
        "Head hair"
    ],
    "Specimen Container(s)": [
        "Omega Specimen Collection Device"
    ],
    "Instrument(s)/Platform(s)": [
        "Micro-plate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-Linked Immunosorbent Assay (ELISA)",
        "Gas Chromatography-Mass Spectrometry (GC/MS)",
        "GC/MS/MS"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Immunoassay",
        "Chemical confirmation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test System",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Omega Laboratories Hair Drug Screening Assay for qualitative detection of opiates, oxycodone, and hydrocodone in hair using ELISA and confirmation by GC/MS.",
    "Indications for Use Summary": "Qualitative detection of morphine and related opiates, oxycodone, and hydrocodone in head hair samples; provides preliminary analytical results requiring confirmation by specific chemical methods for in-house professional use only.",
    "fda_folder": "Toxicology"
}